Clinical trials
Active, not recruiting Phase 3 trials in Lebanon
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 4 |
| Novartis Pharmaceuticals | 3 |
| Agios Pharmaceuticals, Inc. | 2 |
| Alnylam Pharmaceuticals | 1 |
| Amgen | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Celgene | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Forma Therapeutics, Inc. | 1 |
| Immunic AG | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 3 |
| Anemia, Sickle Cell | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Genetic Diseases, Inborn | 2 |
| Hematologic Diseases | 2 |
| Multiple Sclerosis, Chronic Progressive | 2 |
| Sickle Cell Trait | 2 |
| Vaso-Occlusive Crises | 2 |
| Amyloidosis | 1 |
| Amyloidosis, Familial | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.